Identification of patients at risk of acute rejection by pretransplantation and posttransplantation monitoring of soluble CD30 levels in kidney transplantation

被引:39
作者
Sengul, S [1 ]
Keven, K [1 ]
Gormez, U [1 ]
Kutlay, S [1 ]
Erturk, S [1 ]
Erbay, B [1 ]
机构
[1] Ankara Univ, Sch Med, Dept Nephrol, TR-06100 Ankara, Turkey
关键词
renal transplantation; rejection; soluble CD30; immunosuppressive treatment;
D O I
10.1097/01.tp.0000203324.49969.30
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In this study, we investigated the impact of pre- and posttransplantation sCD30 monitoring on early (< 6 months) acute rejection (AR) risk and analyzed the effect of different immunosuppressive regimens on posttransplantation sCD30 levels in kidney recipients. Fifty patients receiving kidney allograft and 10 healthy donors were included in this retrospective cohort study. Eight patients developed biopsy-proven AR (19%). fit pretransplantation samples, patients showed a significantly higher sCD30 than healthy controls. The pretransplantation and posuransplantation (day-15) sCD30 levels were significantly elevated in rejecting patients compared to non-rejecting patients. No significant differences among immunosuppressive regimens were found in posuransplantation sCD30 levels. High pretransplantation and posuransplantation (day 15) sC-D30 levels are associated with increased risk of early AR, and sCD30 can be another toot to evaluate immunological risk prior to kidney transplantation. There was no difference in immunosuppressive regimens used in this study on posuransplantation sCD30 levels at the first month.
引用
收藏
页码:1216 / 1219
页数:4
相关论文
共 16 条
[1]   IL4 production and increased CD30 expression by a unique CD8+ T-cell subset in B-cell chronic lymphocytic leukaemia [J].
de Totero, D ;
Reato, G ;
Mauro, F ;
Cignetti, A ;
Ferrini, S ;
Guarini, A ;
Gobbi, M ;
Grossi, CE ;
Foa, R .
BRITISH JOURNAL OF HAEMATOLOGY, 1999, 104 (03) :589-599
[2]   PREFERENTIAL EXPRESSION OF CD30 BY HUMAN CD4(+) T-CELLS PRODUCING TH2-TYPE CYTOKINES [J].
DELPRETE, G ;
DECARLI, M ;
ALMERIGOGNA, F ;
DANIEL, CK ;
DELIOS, MM ;
ZANCUOGHI, G ;
VINANTE, F ;
PIZZOLO, G ;
ROMAGNANI, S .
FASEB JOURNAL, 1995, 9 (01) :81-86
[3]   Activation of resting human primary T cells with chimeric receptors:: Costimulation from CD28, inducible costimulator, CD134, and CD137 in series with signals from the TCRζ chain [J].
Finney, HM ;
Akbar, AN ;
Lawson, ADG .
JOURNAL OF IMMUNOLOGY, 2004, 172 (01) :104-113
[4]   Regulation of CD30 antigen expression and its potential significance for human disease [J].
Kadin, ME .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (05) :1479-1484
[5]  
Krampera M, 1999, CLIN EXP IMMUNOL, V117, P291
[6]   CD30 antigen: not a physiological marker for TH2 cells but an important costimulator molecule in the regulation of the balance between TH1/TH2 response [J].
Pellegrini, P ;
Berghella, AM ;
Contasta, I ;
Adorno, D .
TRANSPLANT IMMUNOLOGY, 2003, 12 (01) :49-61
[7]   Soluble CD30 as a predictor of kidney graft outcome [J].
Pelzl, S ;
Opelz, G ;
Wiesel, M ;
Schnülle, P ;
Schönemann, C ;
Döhler, B ;
Süsal, C .
TRANSPLANTATION, 2002, 73 (01) :3-6
[8]   Evaluation of posttransplantation soluble CD30 for diagnosis of acute renal allograft rejection [J].
Pelzl, S ;
Opelz, G ;
Daniel, V ;
Wiesel, M ;
Süsal, C .
TRANSPLANTATION, 2003, 75 (03) :421-423
[9]   The Banff 97 working classification of renal allograft pathology [J].
Racusen, LC ;
Solez, K ;
Colvin, RB ;
Bonsib, SM ;
Castro, MC ;
Cavallo, T ;
Croker, BP ;
Demetris, AJ ;
Drachenberg, CB ;
Fogo, AB ;
Furness, P ;
Gaber, LW ;
Gibson, IW ;
Glotz, D ;
Goldberg, JC ;
Grande, J ;
Halloran, PF ;
Hansen, HE ;
Hartley, B ;
Hayry, PJ ;
Hill, CM ;
Hoffman, EO ;
Hunsicker, LG ;
Lindblad, AS ;
Marcussen, N ;
Mihatsch, MJ ;
Nadasdy, T ;
Nickerson, P ;
Olsen, TS ;
Papadimitriou, JC ;
Randhawa, PS ;
Rayner, DC ;
Roberts, I ;
Rose, S ;
Rush, D ;
Salinas-Madrigal, L ;
Salomon, DR ;
Sund, S ;
Taskinen, E ;
Trpkov, K ;
Yamaguchi, Y .
KIDNEY INTERNATIONAL, 1999, 55 (02) :713-723
[10]   High pre-transplant soluble CD30 levels are predictive of the grade of rejection [J].
Rajakariar, R ;
Jivanji, N ;
Varagunam, M ;
Rafiq, M ;
Gupta, A ;
Sheaff, M ;
Sinnott, P ;
Yaqoob, MM .
AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (08) :1922-1925